Bridgepoint to reap 4.8x with $1.5 bln eFront sale

Bridgepoint stands to make 4.8x its money with the sale of eFront, a source said. BlackRock said March 22 that it was buying eFront for $1.3 billion cash. Including debt, the transaction is valued at about $1.5 billion, two people said. BlackRock, New York, is the world’s biggest asset manager. It plans to merge eFront […]

Evox Therapeutics secures 1.5 mln pounds

Evox Therapeutics Ltd said March 22 that it secured 1.5 million pounds ($1.98 million) in funding from Innovate UK through the Biomedical Catalyst Early Stage Award. Evox, of the U.K., is an exosome therapeutics company.


CDPQ buys 27 pct of Hilco Trading

La Caisse de dépôt et placement du Québec said March 21 that it acquired a minority, 27 percent, of Hilco Trading LLC. Financial terms weren’t announced. Hilco, of Chicago, is a diversified financial services company.


Kaarta raises $6.5 mln

Kaarta said May 21 that it raised $6.5 million led by GreenSoil Building Innovation Fund. Riverfront Ventures, Zamagias Properties, Quaker Capital Investments, and Startbot participated in the round. Kaarta, of Pittsburgh, provides 3D reality capture for robotics professionals to map and model indoor and outdoor spaces.

Amify raises $5.8 mln

Amify said March 22 that it raised $5.8 million in Series A funding led by Mercury Fund. Other investors included Dundee Venture Capital, CincyTech, SaaS Venture Capital and Capital One Co-Founder Nigel Morris. Amify, of Alexandria, Virginia, provides solutions that aims to help brands maximize their potential on the Amazon marketplace.


Energy Impact Partners invests in Attivo Networks

Energy Impact Partners has invested in Attivo Networks. Financial terms weren’t announced. Energy Impact Partners is joining Bain Capital, ForgePoint Capital, and Singtel Innov8 in Attivo’s Series C funding round. Attivo, of Freemont, California, provides detection, forensics, and automated incident response to in-network attacks.

Imago BioSciences raised $40 mln

Imago BioSciences Inc said March 21 that it raised $40 million in Series B financing led by Omega Funds. Participating in the round were Frazier Healthcare Partners, Amgen Ventures, and MRL Ventures Fund as well as HighLight Capital, Pharmaron and Greenspring Associates. Imago BioSciences is a clinical-stage biotechnology company developing treatments for myeloid diseases.


Blackwell joins SMS Assist

SMS Assist said March 21 that it hired Graham Blackwell as chief strategy and revenue officer. Blackwell most recently was an executive vice president with Bain Capital’s North American Private Equity Team. SMS Assist raised $150 million from Goldman Sachs Investment Partners in 2016.


Ares Management PE Group buys CoolSys

CoolSys said March 21 that it was sold to the Private Equity Group of Ares Management Corp. Financial terms weren’t announced. Management is investing. CoolSys is a refrigeration and HVAC services company.


Splice raises $57.5 mln

Splice said March 20 that it raised $57.5 million in a Series C round led by existing investors Union Square Ventures and True Ventures. Also participating were DFJ Growth, Flybridge, and Lerer Hippeau, Liontree, Founders Circle Capital, and Matt Pincus, founder of Songz Publishing. Splice is a music startup that aims to help musicians create and earn revenue.


Phillips & Temro buys EVoCharge

Phillips & Temro Industries Inc, a Harbour Group company, said March 20 that it acquired EVoCharge Inc. Financial terms weren’t announced. EvoCharge supplies electric vehicle charging infrastructure solutions for commercial, public vehicle fleet, and residential use.


Guesty raises $35 mln

Guesty said March 21 that it raised $35 million in Series C financing led by Viola Growth. Participating in the round were Vertex Ventures, Journey Ventures, Kingfisher Investment Advisors, La Maison Compagnie d’Investissement and existing investors, TLV Partners and Magma Ventures. Guesty is a property management platform for property managers and management companies.


Sherlock Biosciences launches with $35 mln capital

Sherlock Biosciences said March 21 that it has launched with $35 million in committed capital. This includes a $17.5 million non-dilutive grant and an investment from the Open Philanthropy Project. Sherlock, of Cambridge, Massachusetts, is an engineering biology company that seeks to make testing better, faster and more affordable.


Alvarium Investments buys Iskander

Alvarium Investments, formerly LJ Partnership, said March 21 that it acquired Iskander. Financial terms weren’t announced. Iskander, of France, is an asset manager dedicated to large private investors. Separately, Alvarium is part of Queensgate Investments, which this week acquired four Grange Hotels in Central London in a deal valued at around 1 billion pounds.


PE HUB First Read

To start your morning, we have news that New Zealand is banning assault rifles, Levi Strauss is valued at $6.6 billion as its IPO prices above target, and Fortnite has nearly 250 million registered players.


Ease raises $19 mln

Ease said March 19 that it raised $19 million in a Series B round led by Centana Growth Partners. Propel Venture Partners, Compound Ventures, Freestyle Capital and Upside Partnership participated in the round. Ease, of San Francisco, provides HR and benefits software for SMBs, insurance brokers and insurance carries. Ease first two hires are Petar Nedyalkov as chief operating officer and Toshi Kureha as vice president Engineering.